PROJECTS
EUROPEAN COMMISSION FUNDING SUPPORTS OUR INNOVATIVE CMD-COAT® TECHNOLOGY
New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosis
Coati-X is a €2.5m groundbreaking project funded by the European Innovation Council to deliver a proprietary bioactive coating technology designed to enhance the safety and effectiveness of intravenous catheters and implantable medical devices.
The CM4Cure – FRESCI consortium brings together top researchers, cardiovascular specialists, biologists, chemists and business strategists to validate the coating technology, advancing this innovative solution to market readiness.
The project includes process development, preclinical validation, quality management, regulatory assessment and development of the partnering and commercial strategy. There are more details on the Coati-X website.
Project number: Coati‑X (HORIZON‑EIC‑2023‑TRANSITION‑01)
Meet the Team
Behind this revolutionary platform is a team of leading clinicians, scientists, engineers, and business strategists working to change the future of medical device coatings and patient care.